Literature DB >> 24523453

Does valganciclovir have a role in glioblastoma therapy?

Charles S Cobbs1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24523453      PMCID： PMC3922528          DOI： 10.1093/neuonc/nou009

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  17 in total

1.  Survival in patients with glioblastoma receiving valganciclovir.

Authors:  Cecilia Söderberg-Nauclér; Afsar Rahbar; Giuseppe Stragliotto
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

2.  Cidofovir: a novel antitumor agent for glioblastoma.

Authors:  Piotr Hadaczek; Tomoko Ozawa; Liliana Soroceanu; Yasuyuki Yoshida; Lisa Matlaf; Eric Singer; Estefania Fiallos; C David James; Charles S Cobbs
Journal:  Clin Cancer Res       Date:  2013-10-29       Impact factor: 12.531

3.  High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients.

Authors:  Claudia Januário dos Santos; Lucas Matheus Stangherlin; Eberval Gadelha Figueiredo; Clemar Corrêa; Manoel Jacobsen Teixeira; Maria Cristina Carlan da Silva
Journal:  J Med Virol       Date:  2013-10-30       Impact factor: 2.327

4.  Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.

Authors:  Ninib Baryawno; Afsar Rahbar; Nina Wolmer-Solberg; Chato Taher; Jenny Odeberg; Anna Darabi; Zahidul Khan; Baldur Sveinbjörnsson; O-M FuskevÅg; Lova Segerström; Magnus Nordenskjöld; Peter Siesjö; Per Kogner; John Inge Johnsen; Cecilia Söderberg-Nauclér
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

5.  Generation of a nude mouse tumor model for in vivo replication of human cytomegalovirus.

Authors:  G S Pari; D Netski; S St Jeor; D McCarthy; J Smith; D Georgio; E von Hofe
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

6.  Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype.

Authors:  Liliana Soroceanu; Lisa Matlaf; Vladimir Bezrookove; Loui Harkins; Roxanne Martinez; Mary Greene; Patricia Soteropoulos; Charles S Cobbs
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

Review 7.  Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects.

Authors:  Charles S Cobbs
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

8.  Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Authors:  Giuseppe Stragliotto; Afsar Rahbar; Nina Wolmer Solberg; Anders Lilja; Chato Taher; Abiel Orrego; Birgitta Bjurman; Charlotte Tammik; Petra Skarman; Inti Peredo; Cecilia Söderberg-Nauclér
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396

9.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor.

Authors:  Lisa A Matlaf; Lualhati E Harkins; Vladimir Bezrookove; Charles S Cobbs; Liliana Soroceanu
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240
View more
  5 in total

Review 1.  Cytomegalovirus and glioblastoma; controversies and opportunities.

Authors:  Sean E Lawler
Journal:  J Neurooncol       Date:  2015-02-15       Impact factor: 4.130

Review 2.  Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme.

Authors:  Andrea Schuessler; David G Walker; Rajiv Khanna
Journal:  Front Oncol       Date:  2014-10-07       Impact factor: 6.244

3.  Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.

Authors:  Jiri Bartek; Olesja Fornara; Joanna Maria Merchut-Maya; Apolinar Maya-Mendoza; Afshar Rahbar; Giuseppe Stragliotto; Helle Broholm; Mikael Svensson; Astrid Sehested; Cecilia Söderberg Naucler; Jiri Bartek; Jirina Bartkova
Journal:  Mol Oncol       Date:  2017-06-17       Impact factor: 6.603

Review 4.  An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.

Authors:  Michael J Wells; Steven Jacobson; Paul H Levine
Journal:  Infect Agent Cancer       Date:  2019-11-05       Impact factor: 2.965

5.  Human cytomegalovirus-induced host protein citrullination is crucial for viral replication.

Authors:  Gloria Griffante; Francesca Gugliesi; Selina Pasquero; Valentina Dell'Oste; Matteo Biolatti; Ari J Salinger; Santanu Mondal; Paul R Thompson; Eranthie Weerapana; Robert J Lebbink; Jasper A Soppe; Thomas Stamminger; Virginie Girault; Andreas Pichlmair; Gábor Oroszlán; Donald M Coen; Marco De Andrea; Santo Landolfo
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 17.694
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.